[Updated] Team says rapid Angel-investor enlistment is one reason this is a 'W' for region's LifeSciences
Breast cancer target, regulatory progress and further capital raise action likely.
Seed to B-round scenario begins to emerge, with pharmacogenetic testing a driver.
[updated] With sector veterans on its board and access to capital, this startup girds for raise.
Two Tennessee-born science-centered companies are united
A change at the helm of one of Tennessee's most recognized institutions.
You may not be getting all you can out of your browsing experience
and may be open to security risks!
Consider upgrading to the latest version of your browser or choose on below: